Paul Kenna

Gründer bei Spark Therapeutics Ireland Ltd.

Consumer Services

Health Technology

Aktive Positionen von Paul Kenna

Unternehmen	Position	Beginn	Ende
Spark Therapeutics Ireland Ltd. Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.	Technik-/Wissenschafts-/F&E-Leiter	01.09.2004	-
	Gründer	-	-
Trinity College Dublin	Corporate Officer/Principal	-	-
The Royal College of Physicians	Corporate Officer/Principal	-	-
Irish College of Ophthalmologists	Corporate Officer/Principal	-	-

Trinity College Dublin

Doctorate Degree

International

Irland	4
Vereinigtes Königreich	2

Operativ

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Founder	1

Sektoral

Consumer Services	4
Health Technology	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
Spark Therapeutics Ireland Ltd. Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.	Health Technology

Private Unternehmen

Health Technology